ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02412111
Brief Title: A Phase 3 Study of Tezacaftor (VX-661) in Combination With Ivacaftor (VX-770) in Subjects Aged 12 Years and Older With Cystic Fibrosis (CF), Who Have One F508del-CFTR Mutation and a Second Mutation That Has Been Demonstrated to be Clinically Responsive to Ivacaftor

First Submitted : April 3, 2015
First Submitted that Met QC Criteria : April 3, 2015
First Posted : April 8, 2015 (Estimate)

Results First Submitted : September 30, 2018
Results First Submitted that Met QC Criteria : January 7, 2019
Results First Posted : January 8, 2019

Last Update Submitted that Met QC Criteria : January 7, 2019
Last Update Posted : January 8, 2019